PubMed=12794754; DOI=10.1002/ijc.11188
Ninck S., Reisser C., Dyckhoff G., Helmke B.M., Bauer H., Herold-Mende C.
Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck.
Int. J. Cancer 106:34-44(2003)

PubMed=17557286; DOI=10.1002/ijc.22867
Vasvari G.P., Dyckhoff G., Kashfi F., Lemke B., Lohr J., Helmke B.M., Schirrmacher V., Plinkert P.K., Beckhove P., Herold-Mende C.
Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo.
Int. J. Cancer 121:1697-1704(2007)

PubMed=19223422; DOI=10.2967/jnumed.108.058123
Nothelfer E.-M., Zitzmann-Kolbe S., Garcia-Boy R., Kramer S., Herold-Mende C., Altmann A., Eisenhut M., Mier W., Haberkorn U.
Identification and characterization of a peptide with affinity to head and neck cancer.
J. Nucl. Med. 50:426-434(2009)

PubMed=20149059; DOI=10.1111/j.1600-0714.2009.00864.x
Freier K., Hofele C., Knoepfle K., Gross M., Devens F., Dyckhoff G., Plinkert P.K., Lichter P., Herold-Mende C.
Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.
J. Oral Pathol. Med. 39:382-389(2010)